Sunshine Biopharma Stock Rallies On Canadian Approval For Generic Amoxicillin Sunshine Biopharma (
NASDAQ: SBFM ) shares are trading higher Thursday after securing Canadian regulatory approval for generic amoxicillin.
Sunshine Biopharma Stock Is Surging Thursday: Here's What's Happening Shares of Sunshine Biopharma Inc. (
NASDAQ: SBFM ) are trading higher Thursday after the Florida-based pharmaceutical company announced the launch of a generic prescription drug.
Sunshine Biopharma Unit Launches Generic Anticonvulsant In Canada: Retail Sees ‘Huge Potential’ CEO Steve Slilaty stated that the company is aiming to strengthen its presence in Canada’s generic drugs market, valued at $9.4 billion.
Sunshine Biopharma Boosts Retail Trader Appeal After Canadian Launch Of Generic Cancer Drug Its subsidiary launched Everolimus — a generic version of Novartis’ Afinitor — in the Canadian generic prescription drug market.
The market is filled with gapping stocks in Monday's session. The market is filled with gapping stocks in Monday's session. Let's discover which stocks are showing gap-ups and gap-downs.
What's going on in today's pre-market session As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
Sunshine Biopharma Stock Shoots Higher On Encouraging Data From mRNA-Based Liver Cancer Drug Sunshine Biopharma's K1.1 mRNA-LNP shows promise for HCC treatment in mice, while its 2024 revenue surged 45% to $34.9 million.
